The sonophotocatalytic degradation of pharmaceutical industry wastewater was studied with a TiO2 slurry mode process with UV 125 W medium-pressure mercury lamp coupled with ultrasound (100 W, 33 ± 3 kHz). The degradation of wastewater was investigated in terms of reduction in COD that confirmed the apparent first- order degradation kinetics. The rate constant was greatly affected by catalyst dose, variation in pH, and concentration of oxidant (H2O2).The catalyst concentration was optimized at 1.0 g L−1, pH at 4, and the oxidant concentration at 0.075 g L−1. The first-order rate constants obtained from coupled sonophotocatalysis were two-folds than those obtained from photocatalysis and approximately ten-folds than sonolysis. The COD reduction follows the trend, sonophotocatalysis > photocatalysis > sonocatalytic > sonolysis. The study demonstrates better efficiency of coupled sonophotocatalysis over independent treatment processes.
No takes yet. Share an insight, caveat, or question.
Verma et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: